Evidence map›Paper›PMID 32184583›Full record

Observational studyInternational journal of chronic obstructive pulmonary disease2020

Reduced Serum Concentration of CC16 Is Associated with Severity of Chronic Obstructive Pulmonary Disease and Contributes to the Diagnosis and Assessment of the Disease.

Biaoxue Rong, Tian Fu, Wenlong Gao, Min Li, Congxue Rong, Wen Liu, Hua Liu

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in International journal of chronic obstructive pulmonary disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Biaoxue RongDepartment of Oncology and Gerontology, First Affiliated Hospital, Xi'an Medical University, Xi'an, People's Republic of China.
Tian FuDepartment of Respiratory Medicine, Jining No.1 People's Hospital, Jining, People's Republic of China.
Wenlong GaoInstitute of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou, People's Republic of China.
Min LiNursing Department, Binhe New District Branch, Shenmu Hospital, Yulin City, Shaanxi, People's Republic of China.
Congxue RongComprehensive Medical Department, Zhangye Second People Hospital, Zhangye, People's Republic of China.
Wen LiuDepartment of Respiratory Medicine, Minqin County People's Hospital, Minqin, People's Republic of China.
Hua LiuDepartment of Respiratory Medicine, Gansu Provincial Hospital, Lanzhou, People's Republic of China.
Gansu Provincial Hospital · CNLanzhou University · CNXi'an Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The aim of this study was to reveal the correlations between serum concentration of Clara cell secretory protein (CC16) and clinical parameters of stable chronic obstructive pulmonary disease (COPD). Patients and Methods: Serum concentration of CC16 was determined by enzyme-linked immunosorbent assay (ELISA). The correlations between serum concentration of CC16 and clinical parameters was performed by linear correlation analysis and multiple linear regression analysis. The sensitivity and specificity of serum CC16 for differential diagnosis of COPD were determined by receiver operator characteristic curve (ROC). Results: The serum concentration of CC16 was down-regulated in stable COPD patients compared with healthy control group (p < 0.05). The decreased serum CC16 was negatively related to smoking (p < 0.05), GOLD grading (p < 0.005), mMRC score (p < 0.05) and medical history (p < 0.05) of patients, but positively correlated with pulmonary function (p < 0.05). The smoking, FEV1/FVC values, COPD grading and mMRC scores all affected the concentration of CC16 (p < 0.05). The decreased CC16 was an independent risk factor in the process of deterioration of lung function. The sensitivity and specificity of serum CC16 for identifying COPD reached to 65.3% and 75%. Conclusion: Decreased serum concentration of CC16 correlated with the disease progression of COPD, suggesting that it can be used as an indicator contributing to the diagnosis and assessment of COPD.

Indexed as

Enzyme-Linked Immunosorbent AssayAdultAgedBiomarkersCase-Control StudiesChinaDiagnosis, DifferentialDisease ProgressionDown-RegulationFemaleHumansMaleMiddle AgedPredictive Value of TestsPulmonary Disease, Chronic ObstructiveReproducibility of ResultsBiomarkersSCGB1A1 protein, humanUteroglobinCC16chronic obstructive pulmonary diseaseClara cell secretory protein 16COPD

Identifiers

PMID32184583
PMCPMC7060081
OpenAlexW3008872489

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.